SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending after halting its compounded weight-loss pill offering due to regulatory pressure, sparking widespread community debate over potential short squeezes, management's competence, and the long-term outlook for its diverse telehealth platform despite a recent Super Bowl ad.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is drawing intense attention following a substantial financing amendment that extends its capital runway through 2028, alongside a new collaboration in cotton traceability. This has fueled a sharp divide among traders, with many anticipating a major short squeeze and a repeat of its history of massive price surges, while others warn of a 'dilution machine' and typical crashes after such momentum.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amid sharp price volatility, sparking a fierce community debate where bears predict further crashes, frequently labeling it an "Epstein coin," while bulls view dips as "bear traps" and anticipate a rebound. Many attribute the erratic price movements to market manipulation, with some even linking recent 'dumps' to the Super Bowl halftime show.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending with high anticipation for its upcoming Q4 earnings report, as investors weigh its AI-driven, capital-light model against broader fintech sector headwinds and perceived market manipulation. The community is actively discussing the stock's significant undervaluation and potential for a short squeeze, even as some express caution regarding historical post-earnings volatility.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is a focal point as its strategic acquisition in physical AI sensing, strong revenue growth, and robust balance sheet bolster its leadership within a consolidating lidar market. The community is actively debating its diversified impact across robotics and smart infrastructure, increasingly viewing it as a foundational technology for the expanding physical AI revolution.

Arbor Realty Trust, Inc. operates as a real estate investment trust, which engages in the provision of loan origination and servicing for multifamily, seniors housing, healthcare, and diverse commercial real estate assets. It operates through the Structured Business and Agency Business segments. The Structured Business segment offers a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets. The Agency Business segment focuses on the sale and service of a range of multifamily finance products through the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation. The company was founded by Ivan Kaufman in June 2003 and is headquartered in Uniondale, NY.

Arbor Realty Trust Inc.

Arbor Realty Trust is trending due to a recent credit rating upgrade and significant insider buying, as the community actively debates whether anticipated interest rate cuts will trigger a short squeeze in the heavily-shorted mortgage REIT.

The Kroger Co. engages in the retail grocery business with added convenience to retail pharmacies and fuel centers. Its main focus is on growing households and increasing customer loyalty by delivering great value and convenience, and investing in four strategic pillars: Fresh, Brands, Data & Personalization and Seamless. Its brands include Big K, Smart Way, Heritage Farm, Simple Truth, and Simple Truth Organic. The company was founded by Barney Kroger in 1883 and is headquartered in Cincinnati, OH.

Kroger Co.

Kroger is trending as investors rally behind reports of retail veteran Greg Foran, former Walmart U.S. CEO, taking the helm, seeing his proven operational expertise as key to a fresh strategy in the highly competitive grocery market.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing a significant rebound after recent tech sector pressure, fueling community debate on whether this is a genuine "V-shape recovery" towards new highs or simply a dead cat bounce. This optimism is tempered by cautionary reports regarding potential further market selling and concerns over China's reduced US treasury holdings.

ETF Opportunities Trust - T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF

The T-Rex 2X Long NVIDIA Daily Target ETF (NVDX) is a key talking point, driven by high anticipation for NVIDIA's upcoming Q4 earnings, which many expect to be a blowout, leading the community to discuss recent price dips and past 'DeepSeek FUD' as compelling accumulation opportunities.

BlackRock Institutional Trust Company N.A. - iShares MSCI Canada ETF

iShares MSCI Canada ETF

The iShares MSCI Canada ETF is trending amid renewed US tariff threats and Canada's proactive efforts to diversify trade, even as the Bank of Canada adjusts its monetary policy; this backdrop has fueled community discussion about the Canadian economy's resilience and propelled the ETF to recent new highs.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have been given an average rating of "Moderate Buy" by the five ratings firms that are currently covering the firm...

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Cartesian Therapeutics, Inc. (RNAC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five research firms that are currently covering the firm...

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm...

What is HC Wainwright's Estimate for RNAC FY2025 Earnings?

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Cartesian Therapeutics in a research note issued on...

HC Wainwright Issues Pessimistic Forecast for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price

HC Wainwright cut their price target on Cartesian Therapeutics from $40.00 to $30.00 and set a "buy" rating for the company in a report on Wednesday...

Cartesian Therapeutics (NASDAQ:RNAC) Given New $44.00 Price Target at BTIG Research

BTIG Research increased their price objective on Cartesian Therapeutics from $42.00 to $44.00 and gave the company a "buy" rating in a research note on Friday...

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.read more...

Cantor Fitzgerald Issues Negative Estimate for RNAC Earnings

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Cartesian Therapeutics in a research report issued to...

Wedbush Has Negative Forecast for RNAC FY2025 Earnings

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Research analysts at Wedbush cut their FY2025 earnings estimates for shares of Cartesian Therapeutics in a note issued to investors on...

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Cartesian Therapeutics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.85	--	--	N/A
Q3 '25	-$0.85	-$1.38	-62.92%	MISSED
Q2 '25	-$0.80	$0.50	162.27%	BEAT
Q1 '25	-$0.70	-$0.68	3.03%	BEAT
Q4 '24	-$0.86	-$0.59	31.34%	BEAT

RNAC
Selecta Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RNAC News

RNACSelecta Biosciences Inc